-+ 0.00%
-+ 0.00%
-+ 0.00%

BRAINSWAY COMPLETES ADDITIONAL $6 MILLION MILESTONE-BASED INVESTMENT IN NEUROLIEF LTD. FOLLOWING FDA APPROVAL OF PROLIV™RX SYSTEM FOR MDD

Reuters·03/26/2026 11:30:00

Please log in to view news